Cargando…

Significant Therapeutic Effects of Adult Human Neural Stem Cells for Spinal Cord Injury Are Mediated by Monocyte Chemoattractant Protein-1 (MCP-1)

The limited capability of regeneration in the human central nervous system leads to severe and permanent disabilities following spinal cord injury (SCI) while patients suffer from no viable treatment option. Adult human neural stem cells (ahNSCs) are unique cells derived from the adult human brain,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Chung Kwon, Won, Jeong-Seob, An, Jae Yeol, Lee, Ho Jin, Nam, Ah-Jin, Nam, Hyun, Lee, Ji Yeoun, Lee, Kyung-Hoon, Lee, Sun-Ho, Joo, Kyeung Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029183/ https://www.ncbi.nlm.nih.gov/pubmed/35457084 http://dx.doi.org/10.3390/ijms23084267

Ejemplares similares

Phagocyte Chemoattraction Is Induced through the Mcp-1–Ccr2 Axis during Efferocytosis
por: Lee, Sang-Ah, et al.
Publicado: (2021)

Monocyte Chemoattractant Protein-1 (MCP-1) Regulates Macrophage Cytotoxicity in Abdominal Aortic Aneurysm
por: Wang, Qiwei, et al.
Publicado: (2014)

Association of Monocyte Chemoattractant Protein-1 (MCP-1) 2518A/G Polymorphism with Proliferative Diabetic Retinopathy in Korean Type 2 Diabetes
por: Jeon, Hyun Jeong, et al.
Publicado: (2013)

Advances in Neural Stem Cell Therapy for Spinal Cord Injury: Safety, Efficacy, and Future Perspectives
por: Lee, Sungjoon, et al.
Publicado: (2022)

An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-lpr Mouse Model
por: Gong, Jiang-Hong, et al.
Publicado: (1997)

Decreased Serum Monocyte Chemoattractant Protein-1 (MCP-1) Expression in Patients with Upper Gastrointestinal Bleeding
por: Xing, Guohui, et al.
Publicado: (2019)

Murine Monocyte Chemoattractant Protein (MCP)-5: A Novel CC Chemokine That Is a Structural and Functional Homologue of Human MCP-1
por: Sarafi, Mindy N., et al.
Publicado: (1997)

In vivo distribution of U87MG cells injected into the lateral ventricle of rats with spinal cord injury
por: Won, Jeong-Seob, et al.
Publicado: (2018)

Phyllostachys edulis Compounds Inhibit Palmitic Acid-Induced Monocyte Chemoattractant Protein 1 (MCP-1) Production
por: Higa, Jason K., et al.
Publicado: (2012)

Circulating monocyte chemoattractant protein‐1 (MCP‐1) is associated with cachexia in treatment‐naïve pancreatic cancer patients
por: Talbert, Erin E., et al.
Publicado: (2018)

Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis
por: Mulholland, Bridie S., et al.
Publicado: (2019)

Monocyte chemoattractant protein (MCP)-1 −2518 A/G SNP in Chinese Han patients with VKH syndrome
por: Hou, Shengping, et al.
Publicado: (2009)

RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis
por: Lloyd, Clare M., et al.
Publicado: (1997)

Bioluminescence imaging of mouse monocyte chemoattractant protein-1 expression in inflammatory processes: Bioluminescence imaging of mouse MCP-1 expression
por: Shao, Fangyang, et al.
Publicado: (2022)

Optimal Preclinical Conditions for Using Adult Human Multipotent Neural Cells in the Treatment of Spinal Cord Injury
por: Won, Jeong-Seob, et al.
Publicado: (2021)

Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes
por: Mojsilovic-Petrovic, Jelena, et al.
Publicado: (2007)

Adult Human Multipotent Neural Cells Could Be Distinguished from Other Cell Types by Proangiogenic Paracrine Effects via MCP-1 and GRO
por: Kim, Sung Soo, et al.
Publicado: (2021)

Analysis of the Monocyte Chemoattractant Protein 1 -2518 Promoter Polymorphism in Korean Patients with Alopecia Areata
por: Hong, Seok-Beom, et al.
Publicado: (2006)

Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy
por: Zungsontiporn, Nath, et al.
Publicado: (2016)

Monocyte chemoattractant protein-1 (MCP-1)-2518 A/G polymorphism and lupus nephritis risk: A PRISMA-compliant meta-analysis
por: Sang, Guo-Yao, et al.
Publicado: (2017)

Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1
por: Mitchell, Ryan M, et al.
Publicado: (2009)

Monocyte chemoattractant protein-1 gene (MCP-1-2518 A/G) polymorphism and serological markers of hepatitis B virus infection in hemodialysis patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2014)

Association of Polymorphisms in Monocyte Chemoattractant Protein-1 Promoter with Diabetic Kidney Failure in Korean Patients with Type 2 Diabetes Mellitus
por: Moon, Ju-young, et al.
Publicado: (2007)

Monocyte Chemoattractant Protein-1 in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Biomarker Potential and Association with Polymorphisms in the MCP-1 and the CC Chemokine Receptor-2 Gene
por: Jönsson, Nina, et al.
Publicado: (2018)

In Vivo Spinal Distribution of Cy5.5 Fluorescent Dye after Injection via the Lateral Ventricle and Cisterna Magna in Rat Model
por: Lee, Kee-Hang, et al.
Publicado: (2018)

Circulating Monocyte Chemoattractant Protein-1 Levels and Lumbar Bone Mineral Density in Korean Women
por: Lee, Seong-Kyu
Publicado: (2017)

Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011)

Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction
por: Morimoto, Hajime, et al.
Publicado: (2007)

Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy
por: Chung, Choon Hee, et al.
Publicado: (2015)

Altered Expression of Heat Shock Protein-27 and Monocyte Chemoattractant Protein-1 after Acute Spinal Cord Injury: A Pilot Study
por: Boraiah, Vidyasagar, et al.
Publicado: (2019)

Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
por: Petrkova, Jana, et al.
Publicado: (2004)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Astragalus membranaceus Inhibits Peritoneal Fibrosis via Monocyte Chemoattractant Protein (MCP)-1 and the Transforming Growth Factor-β1 (TGF-β1) Pathway in Rats Submitted to Peritoneal Dialysis
por: Li, Zhenghong, et al.
Publicado: (2014)

Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice
por: Lu, Bao, et al.
Publicado: (1998)

Granulocyte Colony Stimulating Factor (GCSF) Can Attenuate Neuropathic Pain by Suppressing Monocyte Chemoattractant Protein-1 (MCP-1) Expression, through Upregulating the Early MicroRNA-122 Expression in the Dorsal Root Ganglia
por: Liao, Ming-Feng, et al.
Publicado: (2020)

Regulatory Roles of Osteopontin in Production of Monocyte-Origin MCP-1
por: Shi, Liying, et al.
Publicado: (2018)

Relationship between dietary folate intake and plasma monocyte chemoattractant protein-1 and interleukin-8 in heart failure patients
por: Chung, Hye Kyung, et al.
Publicado: (2011)

Age-related change of Iba-1 immunoreactivity in the adult and aged gerbil spinal cord
por: Lee, Kwon Young, et al.
Publicado: (2017)

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999)

The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder
por: Pae, Chi-Un
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dq24175646s05b9renn7u9b1uc